Sintana Announces Closing of Oversubscribed Public Offering to Raise Gross Proceeds of $13,282,500 and Completion of Acquisition of Petroleum Exploration License Interests in Namibia

Written by Customer Service on March 8, 2022. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSXV: SEI) (the “Company” or “Sintana”) is pleased to announce that it has closed its previously announced marketed public offering (the “Offering”) conducted by Echelon Capital Markets (the “Agent”) as lead agent and sole bookrunner, pursuant to which it issued an aggregate of 88,550,000 units (the “Units”) of the Company, at a price of $0.15 per Unit, to raise aggregate gross proceeds of $13,282,500 (including full exercise of an over-allotment option). The Offering was effected pursuant to a final short form prospectus of the Company dated February 24, 2022 (the “Final Prospectus”), and was upsized from the originally announced maximum base offering of $10 million...

Biomea Fusion Announces Upcoming Presentations of Preclinical Data in Diffuse Large B-Cell Lymphoma, Multiple Myeloma, and Several KRAS Mutant Solid Tumors for BMF-219 at AACR Annual Meeting 2022

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Irreversible covalent menin inhibitor, BMF-219, exhibited high potency and complete growth inhibition in high-grade B-cell lymphoma and multiple myeloma (MM) preclinical patient derived ex vivo models BMF-219 demonstrated high potency in various KRAS-mutant cell lines, as well as potential advantages over the KRAS-targeted inhibitor sotorasib in multiple cell lines BMF-219 showed strong potency in ex vivo preclinical models of colorectal cancer (CRC), non-small cell lung cancer (NSCLC), and pancreatic cancer REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel irreversible covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic...

Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Context to host webinar with AACR presenters on Wednesday, April 13, 2022, at 11 a.m. ET PHILADELPHIA, March 08, 2022 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that five abstracts have been selected for poster or symposium presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13, 2022, at the Ernest N. Morial Convention Center in New Orleans, LA. “Context is committed to advancing new therapeutics for female cancers and we are proud to have our compounds showcased at the upcoming AACR Annual Meeting,” said Martin Lehr, CEO of Context Therapeutics. “We look forward to the presentations from investigators...

Kinnate Biopharma Inc. Announces Acceptance of Abstracts for Presentation at the American Association for Cancer Research Annual Meeting

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Poster presentations to highlight data from ongoing studies of the company’s lead Pan-RAF kinase inhibitor program, KIN-2787 SAN FRANCISCO and SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced abstracts highlighting the company’s lead RAF kinase inhibitor program, KIN-2787, have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, to be held April 8-13, in New Orleans, Louisiana. Abstracts accepted for poster presentation include: Occurrence of BRAF class II and III alterations is common across solid tumors and is associated with inferior clinical outcomes...

Premier Diversified Holdings Inc. Announces New Loan Agreement and Amended Loans

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Not for dissemination in the United States of America. VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — Loan Agreement Premier Diversified Holdings Inc. (“Premier” or the “Company“) (TSXV: PDH) announces that it has entered into a loan agreement with MPIC Fund I, LP (“MPIC“) for a secured loan in the principal amount of up to USD$120,000 (the “Loan“). The Loan matures on February 10, 2023 and bears interest at a rate of 6% per annum. The Loan is secured with all of the present and after-acquired property of the Company and ranks equally in priority with all of the loans previously made to the Company by MPIC. The Loan will be used for working capital (including for Premier’s partially owned subsidiaries, Purposely Platform Inc. and MyCare MedTech Inc.) and may be used...

Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea’s neoantigen-targeted peripheral T cell therapy for solid tumors The PLANET manufacturing process reliably generates abundant, high-quality neoantigen-specific T cells Preclinical data indicate that Inhibigens™ accelerate tumor growth in animal models of pancreatic cancer and melanoma CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will present clinical, preclinical, and manufacturing data at next month’s American Association for Cancer Research (AACR) Annual Meeting 2022 to be held from April 8-13 in New Orleans. The findings include late-breaking clinical data from the TiTAN™ clinical trial for the neoantigen-targeted...

Targa Resources Corp. to Participate in Evercore ISI Elite Energy & Materials Summit

Written by Customer Service on March 8, 2022. Posted in Public Companies.

HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that representatives from the Company will participate in investor meetings via video conference at the Evercore ISI Elite Energy & Materials Summit on Wednesday, March 9, 2022. A copy of the slides used for the conference meetings will be available in the Investors section of the Company’s website at www.targaresources.com, or by going to https://www.targaresources.com/investors/events. About Targa Resources Corp. Targa Resources Corp. is a leading provider of midstream services and is one of the largest independent midstream infrastructure companies in North America. The Company owns, operates, acquires and develops a diversified portfolio of complementary midstream infrastructure...

W&T Offshore Announces Fourth Quarter and Full Year 2021 Results Including Year-End 2021 Proved Reserves; Provides Guidance for 2022

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today reported operational and financial results for the fourth quarter and full year 2021, including the Company’s year-end 2021 reserve report. Guidance for 2022 was also provided. This press release includes non-GAAP financial measures, including Adjusted Net Income, Adjusted EBITDA, Free Cash Flow, and Net Debt, which are described and reconciled to the most comparable GAAP measures below in the accompanying tables under “Non-GAAP Information.” Key highlights for the fourth quarter and full year 2021 included: Increased production by 7% to 37.2 thousand barrels of oil equivalent per day (“MBoe/d”) (45% liquids), or 3.4 million barrels of oil equivalent (“MMBoe”), in the fourth quarter of 2021 compared to the prior quarter...

17 Education & Technology Group Inc. Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

BEIJING, March 08, 2022 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), an education technology company in China, today announced its unaudited financial results for the fourth quarter and the year ended December 31, 2021. The General Office of the CPC Central Committee and the General Office of the State Council published the “Opinions on Further Alleviating the Burden of Homework and After-School Tutoring on Students in Compulsory Education” in July 2021 (the “Opinion”), also known as the double reduction policy (the “Double Reduction Policy”), and competent authorities promulgated the related implementation rules, regulations and measures (collectively, the “New Regulations”). The Company had provided updates on the New Regulations and related regulatory development...

Dada Announces Unaudited Fourth Quarter and Fiscal Year 2021 Financial Results

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, March 08, 2022 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand delivery and retail platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter and Fiscal Year 2021 Highlights Total net revenues in the fourth quarter were RMB2,032.1 million. Total net revenues in 2021 were RMB6,866.3 million. Total Gross Merchandise Volume (“GMV”) of JDDJ in 2021 was RMB43.1 billion, an increase of 70.5% year over year from RMB25.3 billion in 2020. Number of active consumers in 2021 was 62.3 million, as compared with 41.3 million in 2020. “We are delighted to conclude 2021 with another strong quarter,” said Mr. Philip Kuai, Chairman and Chief Executive Officer of Dada. “We are excited to announce...

Day: March 8, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice